BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 10383728)

  • 1. Profilaggrin requires both linker and filaggrin peptide sequences to form granules: implications for profilaggrin processing in vivo.
    Kuechle MK; Thulin CD; Presland RB; Dale BA
    J Invest Dermatol; 1999 Jun; 112(6):843-52. PubMed ID: 10383728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional analysis of the profilaggrin N-terminal peptide: identification of domains that regulate nuclear and cytoplasmic distribution.
    Pearton DJ; Dale BA; Presland RB
    J Invest Dermatol; 2002 Sep; 119(3):661-9. PubMed ID: 12230510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transient expression of epidermal filaggrin in cultured cells causes collapse of intermediate filament networks with alteration of cell shape and nuclear integrity.
    Dale BA; Presland RB; Lewis SP; Underwood RA; Fleckman P
    J Invest Dermatol; 1997 Feb; 108(2):179-87. PubMed ID: 9008231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of protease processing sites during conversion of rat profilaggrin to filaggrin.
    Resing KA; Johnson RS; Walsh KA
    Biochemistry; 1993 Sep; 32(38):10036-45. PubMed ID: 8399131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of mouse profilaggrin: evidence for nuclear engulfment and translocation of the profilaggrin B-domain during epidermal differentiation.
    Zhang D; Karunaratne S; Kessler M; Mahony D; Rothnagel JA
    J Invest Dermatol; 2002 Oct; 119(4):905-12. PubMed ID: 12406337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for specific proteolytic cleavage of the N-terminal domain of human profilaggrin during epidermal differentiation.
    Presland RB; Kimball JR; Kautsky MB; Lewis SP; Lo CY; Dale BA
    J Invest Dermatol; 1997 Feb; 108(2):170-8. PubMed ID: 9008230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inducible expression of filaggrin increases keratinocyte susceptibility to apoptotic cell death.
    Kuechle MK; Presland RB; Lewis SP; Fleckman P; Dale BA
    Cell Death Differ; 2000 Jun; 7(6):566-73. PubMed ID: 10822280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of normal profilaggrin and filaggrin in flaky tail (ft/ft) mice: an animal model for the filaggrin-deficient skin disease ichthyosis vulgaris.
    Presland RB; Boggess D; Lewis SP; Hull C; Fleckman P; Sundberg JP
    J Invest Dermatol; 2000 Dec; 115(6):1072-81. PubMed ID: 11121144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass spectrometric analysis of 21 phosphorylation sites in the internal repeat of rat profilaggrin, precursor of an intermediate filament associated protein.
    Resing KA; Johnson RS; Walsh KA
    Biochemistry; 1995 Jul; 34(29):9477-87. PubMed ID: 7626618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the human epidermal profilaggrin gene. Genomic organization and identification of an S-100-like calcium binding domain at the amino terminus.
    Presland RB; Haydock PV; Fleckman P; Nirunsuksiri W; Dale BA
    J Biol Chem; 1992 Nov; 267(33):23772-81. PubMed ID: 1429717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Filaggrin, an intermediate filament-associated protein: structural and functional implications from the sequence of a cDNA from rat.
    Haydock PV; Dale BA
    DNA Cell Biol; 1990 May; 9(4):251-61. PubMed ID: 1693512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of profilaggrin endoproteinase 1. A regulated cytoplasmic endoproteinase of epidermis.
    Resing KA; Thulin C; Whiting K; al-Alawi N; Mostad S
    J Biol Chem; 1995 Nov; 270(47):28193-8. PubMed ID: 7499312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural properties of target binding by profilaggrin A and B domains and other S100 fused-type calcium-binding proteins.
    Hinbest AJ; Kim SR; Eldirany SA; Lomakin IB; Watson J; Ho M; Bunick CG
    J Dermatol Sci; 2020 Oct; 100(1):39-49. PubMed ID: 32893105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Filaggrin].
    Sarret Y; Reano A; Kanitakis J; Thivolet J
    Pathol Biol (Paris); 1989 Apr; 37(4):297-303. PubMed ID: 2660081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple copies of phosphorylated filaggrin in epidermal profilaggrin demonstrated by analysis of tryptic peptides.
    Resing KA; Dale BA; Walsh KA
    Biochemistry; 1985 Jul; 24(15):4167-75. PubMed ID: 4052387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is filaggrin really a filament-aggregating protein in vivo?
    Weidenthaler B; Hausser I; Anton-Lamprecht I
    Arch Dermatol Res; 1993; 285(3):111-20. PubMed ID: 8503690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profilaggrin is a major epidermal calcium-binding protein.
    Markova NG; Marekov LN; Chipev CC; Gan SQ; Idler WW; Steinert PM
    Mol Cell Biol; 1993 Jan; 13(1):613-25. PubMed ID: 8417356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the amino terminus of human filaggrin using differential LC/MS techniques: implications for profilaggrin processing.
    Thulin CD; Walsh KA
    Biochemistry; 1995 Jul; 34(27):8687-92. PubMed ID: 7612609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translocation of profilaggrin N-terminal domain into keratinocyte nuclei with fragmented DNA in normal human skin and loricrin keratoderma.
    Ishida-Yamamoto A; Takahashi H; Presland RB; Dale BA; Iizuka H
    Lab Invest; 1998 Oct; 78(10):1245-53. PubMed ID: 9800950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Filaggrin expression in epidermolytic ichthyosis (epidermolytic hyperkeratosis).
    Ishida-Yamamoto A; Eady RA; Underwood RA; Dale BA; Holbrook KA
    Br J Dermatol; 1994 Dec; 131(6):767-79. PubMed ID: 7531997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.